-
www.qualitymeasures.ahrq.gov/sites/default/files/wysiwyg/policymakers/chipra/factsheets/fullreports/0082maternity.pdf
February 23, 2012 - birth-related,
short-term adverse effects, substance use during pregnancy also can lead to long-
term developmental … Adverse effects of prenatal alcohol exposure can range from
subtle developmental problems, or fetal
-
www.qualitymeasures.ahrq.gov/sites/default/files/wysiwyg/pqmp/measures/perinatal/chipra-mc4-fullreport.pdf
July 01, 2016 - • The extent to which the measure is applicable to changes across developmental
stages (e.g., infancy
-
www.qualitymeasures.ahrq.gov/sites/default/files/wysiwyg/pqmp/measures/perinatal/chipra-0084-fullreport.pdf
March 01, 2016 - • The extent to which the measure is applicable to changes across developmental
stages (e.g., infancy
-
www.qualitymeasures.ahrq.gov/sites/default/files/wysiwyg/policymakers/chipra/demoeval/what-we-learned/perspectives-quality-improvement-collaboratives.pdf
January 01, 2018 - It also includes screening patients for developmental delays, autism spectrum disorder conditions, lead
-
www.qualitymeasures.ahrq.gov/sites/default/files/wysiwyg/research/findings/nhqrdr/2023-NHQDR-appendixes-ACDE-rev.pdf
January 01, 2023 - physical, occupational, or speech therapy; and
■ Need or use of treatment or counseling for emotional, developmental … physical, occupational, or speech therapy; and the need or use of
treatment or counseling for emotional, developmental … International Classification of Diseases, Tenth Revision, Clinical Modification
• IDD: intellectual/developmental
-
www.qualitymeasures.ahrq.gov/sites/default/files/wysiwyg/pqmp/measures/availability/chipra-237-fullreport.pdf
October 01, 2019 - cardiovascular diseases.
6
• The extent to which the measure is applicable to changes across developmental
-
www.qualitymeasures.ahrq.gov/sites/default/files/wysiwyg/pqmp/measures/chronic/chipra-246-fullreport.pdf
December 01, 2019 - • The extent to which the measure is applicable to changes across developmental
stages (e.g., infancy
-
www.qualitymeasures.ahrq.gov/sites/default/files/wysiwyg/pqmp/measures/perinatal/chipra-0082-fullreport.pdf
March 01, 2016 - • The extent to which the measure is applicable to changes across developmental
stages (e.g., infancy
-
www.qualitymeasures.ahrq.gov/sites/default/files/wysiwyg/pqmp/measures/perinatal/chipra-0083-fullreport.pdf
March 01, 2016 - • The extent to which the measure is applicable to changes across developmental
stages (e.g., infancy
-
www.qualitymeasures.ahrq.gov/sites/default/files/wysiwyg/pqmp/measures/chronic/chipra-247-fullreport.pdf
December 01, 2019 - • The extent to which the measure is applicable to changes across developmental
stages (e.g., infancy
-
www.qualitymeasures.ahrq.gov/sites/default/files/wysiwyg/pqmp/measures/chronic/chipra-201-fullreport.pdf
March 01, 2019 - • The extent to which the measure is applicable to changes across developmental
stages (e.g., infancy
-
www.qualitymeasures.ahrq.gov/sites/default/files/wysiwyg/policymakers/chipra/demoeval/what-we-learned/chipra-primary-care-physician-reporting.pdf
December 01, 2016 - up-to-date immunizations at age 2 years, up-to-date immunizations at age 13 years, bodymass index
screening, developmental
-
www.qualitymeasures.ahrq.gov/sites/default/files/wysiwyg/pqmp/measures/acute/chipra-228-fullreport.pdf
February 01, 2018 - • The extent to which the measure is applicable to changes across developmental
stages (e.g., infancy
-
www.qualitymeasures.ahrq.gov/sites/default/files/wysiwyg/pqmp/measures/chronic/chipra-166-fullreport.pdf
March 01, 2018 - • The extent to which the measure is applicable to changes across developmental
stages (e.g., infancy
-
www.qualitymeasures.ahrq.gov/sites/default/files/wysiwyg/pqmp/measures/chronic/chipra-244-fullreport.pdf
December 01, 2019 - • The extent to which the measure is applicable to changes across developmental
stages (e.g., infancy
-
www.qualitymeasures.ahrq.gov/sites/default/files/wysiwyg/pqmp/measures/chronic/chipra-245-fullreport.pdf
December 01, 2019 - • The extent to which the measure is applicable to changes across developmental
stages (e.g., infancy
-
www.qualitymeasures.ahrq.gov/patient-safety/resources/learning-lab/index.html
February 01, 2024 - and spread this care pathway across the United States via the American Academy of Cerebral Palsy and Developmental
-
www.qualitymeasures.ahrq.gov/sites/default/files/wysiwyg/pqmp/measures/acute/chipra-194-fullreport.pdf
April 01, 2019 - • The extent to which the measure is applicable to changes across developmental
stages (e.g., infancy
-
www.qualitymeasures.ahrq.gov/sites/default/files/wysiwyg/pqmp/measures/acute/chipra-0197-fullreport.pdf
November 01, 2019 - • The extent to which the measure is applicable to changes across developmental
stages (e.g., infancy
-
www.qualitymeasures.ahrq.gov/sites/default/files/wysiwyg/pqmp/measures/acute/chipra-196-fullreport.pdf
January 01, 2020 - • The extent to which the measure is applicable to changes across developmental
stages (e.g., infancy